additional drugs: Clients receiving treatment for their own drug use nominate a principal drug of concern that has led them to seek treatment and additional drugs of concern, of which up to 5 are recorded in the AODTS NMDS. Clients receiving treatment for someone else's drug use do not nominate drugs of concern.
administrative cessation: Includes episodes that ended due to a change in main treatment type, delivery setting or principal drug of concern, or where the client was transferred to another service provider.
alcohol: A central nervous system depressant made from fermented starches. Alcohol inhibits brain functions, dampens the motor and sensory centres and makes judgement, coordination and balance more difficult.
closed treatment episode: A period of contact between a client and a treatment provider or team of providers. An episode is closed when treatment is completed, there has been no further contact between the client and the treatment provider for 3 months or when treatment is ceased (see reason for cessation).
expected cessation: Includes episodes where the treatment was completed, or where the client ceased to participate at expiation or by mutual agreement.
main treatment type: The principal activity that is determined at assessment by the treatment provider to treat the client's alcohol or other drug problem for the principal drug of concern.
methadone program: A program for opiate addicts, usually conducted in an outpatient setting. These programs use a long-acting synthetic opiate medication, usually methadone or levo-alpha acetyl methadol, administered orally for a sustained period at a dosage sufficient to prevent opiate withdrawal, block the effects of illicit opiate use and decrease opiate craving.
non-maintenance: Use of a substance other than as part of a medically supervised maintenance program (this includes methadone).
non-medical use: Use of drugs either alone or with other drugs to induce or enhance a drug experience, for performance enhancement or for cosmetic purposes (this includes pain-killers/analgesics, tranquilisers/sleeping pills, steroids and meth/amphetamines and other opioids such as morphine or pethidine).
opiate/opioid substitution treatment (OST): A form of healthcare for heroin and other opiate-dependent people using prescribed opioid agonists, which have some similar or identical properties to heroin and morphine on the brain and which alleviate withdrawal symptoms and block the craving for illicit opiates. OST includes methadone, buprenorphine, and buprenorphine with naloxone.
principal drug of concern: The main substance that the client stated led them to seek treatment from an alcohol and drug treatment agency.
reason for cessation: The reason for the client ceasing to receive a treatment episode from an alcohol and other drug treatment service:
treatment completed: Where the treatment was completed as planned
transferred to another service provider: This includes situations where the service provider is no longer the most appropriate and the client is transferred or referred to another service. For example, transfers could occur for clients between non-residential and residential services or between residential services and a hospital. This excludes situations where the original treatment was completed before the client transferred to a different provider for other treatment.
treatment type: The type of activity that is used to treat the client's alcohol or other drug problem:
treatment episode: The period of contact between a client and a treatment provider or a team of providers. Each treatment episode has 1 principal drug of concern and 1 main treatment type. If the principal drug or main treatment changes, then a new episode is recorded.
unexpected cessation: Includes episodes where the client ceased to participate against advice, without notice or due to non-compliance.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.